Table 2

Clinical characteristics and measures of Mycobacterium tuberculosis infection in adults and children in recent household contact with a tuberculosis index case

All subjects(n = 82)Children(n = 29)Adults(n = 53)
Mean (SD) age (years)†22.8 (18.1)2.9 (2.6)33.8 (12.8)
% with documented BCG vaccination75.6 (62/82)100 (29/29)62.2 (33/53)
TST (%)†
    Positive*†69.2 (54/78)53.6 (15/28)78.0 (39/50)
    Not read4.9 (4/82)3.5 (1/29)5.7 (3/53)
T-SPOT.TB (%)
    Positive†75.0 (60/80)92.6 (25/27)66.0 (35/53)
    Indeterminate1.2 (1/81)3.6 (1/28)0 (0/53)
QTF (%)
    Positive40.9 (29/71)44.4 (8/18)39.6 (21/53)
    Indeterminate4.1 (3/74)14.3 (3/21)0 (0/53)
Mean (SD) M tuberculosis contact score†6.4 (5.6)10.2 (3.5)4.3 (5.4)
Proportion with high M tuberculosis contact score (⩾4)‡†59.8 (49/82)93.1 (27/29)41.5 (22/53)
  • Data shown as % (n) unless otherwise stated.

  • BCG, Bacille Calmette-Guérin (BCG vaccination documented, documented on the clinic card or the presence of a BCG scar); QTF, Quantiferon-Gold; TST, tuberculin skin test (TST ⩾10 mm classified as positive).

  • †Significant difference between adults and children (indeterminate results for interferon γ release assay excluded); *p⩽0.0001 for mean contact score between adults and children (two-sided t test).

  • ‡High M tuberculosis contact score defined as a score ⩾4; low score as <4.

  • T-SPOT.TB was preferentially completed in children when <10 ml blood available.

  • Failed phlebotomy was defined as 10 ml blood not obtained in children: 3.4% (1/29) for T-SPOT.TB and 27.6% (8/29) for QTF.

  • Significant difference (McNemar χ2 test; p<0.05) between the proportions of subjects with positive test results in the following groups: TST vs T-SPOT.TB in children: p = 0.007; TST vs QTF in all subjects: p<0.001; TST vs QTF in adults: p<0.001; T-SPOT.TB vs QTF in all subjects: p<0.001; T-SPOT.TB vs QTF in adults: p<0.001; T-SPOT.TB vs QTF in children: p<0.020.